FDA Adverse Event Malfunction Summary report: N

0.50MCI 1251 BRACHYSOURCE

MDR report key: 11854136 · Received May 20, 2021

Report

Report Number
1018233-2021-02922
Event Type
Malfunction
Date Received
May 20, 2021
Date of Event
April 22, 2021
Report Date
February 2, 2022
Manufacturer
BARD BRACHYTHERAPY, INC. -1424526
Product Code
KXK
PMA / PMN Number
K093663
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

H10: THE INITIAL MDR WAS INADVERTENTLY SUBMITTED WITH A G3 DATE OF 04-26-2021. THE CORRECT G3 DATE IS 04-23-2021. H10: MANUFACTURING REVIEW: THE DEVICE HISTORY RECORD REVIEW WAS PERFORMED FOR THE REPORTED LOT NUMBER AND THIS LOT MET ALL RELEASE CRITERIA. THE MANUFACTURING REVIEW DID NOT INDICATE ANY POSSIBLE MANUFACTURING ISSUE THAT COULD BE RELATED TO THE REPORTED EVENT. INVESTIGATION SUMMARY: THE SAMPLE WAS NOT RETURNED FOR EVALUATION. THEREFORE, THE INVESTIGATION IS INCONCLUSIVE FOR THE REPORTED ISSUE. A DEFINITIVE ROOT CAUSE COULD NOT BE DETERMINED BASED UPON THE AVAILABLE INFORMATION. LABELING REVIEW: A REVIEW OF PRODUCT LABELING DOCUMENTATION (E.G. PROCEDURAL INSTRUCTIONS, INDICATIONS, WARNINGS, PRECAUTIONS, CAUTIONS, POSSIBLE COMPLICATIONS, CONTRAINDICATIONS, NURSING GUIDE, AND UNIT LABEL) DID NOT FIND ANY PRODUCT LABELING INADEQUACY. THE INFORMATION FOR USE WAS REVIEWED. THERE IS A CAUTION STATEMENT, WHICH STATES "IF ANY RADIOACTIVE MATERIAL CANNOT BE ACCOUNTED FOR, THE LOSS MUST BE REPORTED TO THE APPROPRIATE LICENSING AGENCY." H10: (EXPIRY DATE: 09/2021). H11: SECTION A THROUGH F ¿ THE INFORMATION PROVIDE BY BD REPRESENTS ALL THE KNOWN INFORMATION AT THIS TIME. DESPITE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL INFORMATION, THE COMPLAINANT/REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO BD. H3 OTHER TEXT: DEVICE NOT RETURNED.

Additional Manufacturer Narrative · 0

H10: THE FILE WAS REASSESSED FOR REPORTABILITY AND DETERMINED TO BE NO LONGER REPORTABLE. SINCE AN INITIAL MDR WAS SUBMITTED, THEREFORE, THE FILE WILL REMAIN ASSESSED AS A MALFUNCTION. H10: D4 (EXPIRY DATE: 09/2021). H11: SECTION A THROUGH F ¿ THE INFORMATION PROVIDE BY BD REPRESENTS ALL THE KNOWN INFORMATION AT THIS TIME. DESPITE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL INFORMATION, THE COMPLAINANT/REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO BD. H3 OTHER TEXT : DEVICE NOT RETURNED.

Description of Event or Problem · 0

IT WAS REPORTED THAT DURING A PROCEDURE, ONE GRAIN OF THE DEVICE WAS ALLEGEDLY FOUND TO BE MISSING FROM THE PARCEL. THERE WAS NO REPORTED PATIENT INJURY.

Description of Event or Problem · 0

IT WAS REPORTED THAT DURING A PROCEDURE, ONE GRAIN OF THE DEVICE WAS ALLEGEDLY FOUND TO BE MISSING FROM THE PARCEL. THERE WAS NO REPORTED PATIENT INJURY.

Additional Manufacturer Narrative · 1

MANUFACTURING REVIEW: THE DEVICE HISTORY RECORD REVIEW WAS PERFORMED FOR THE REPORTED LOT NUMBER AND THIS LOT MEETS ALL RELEASE CRITERIA. THE MANUFACTURING REVIEW DID NOT INDICATE ANY POSSIBLE MANUFACTURING ISSUE THAT COULD BE RELATED TO THE REPORTED EVENT. INVESTIGATION SUMMARY: THE SAMPLE WAS NOT RETURNED FOR EVALUATION. THE INVESTIGATION IS INCONCLUSIVE, AND THE ROOT CAUSE IS UNDETERMINED. LABELING REVIEW: LABELING WAS REVIEWED AND FOUND TO BE ADEQUATE. THERE IS A CAUTION STATEMENT, WHICH STATES "IF ANY RADIOACTIVE MATERIAL CANNOT BE ACCOUNTED FOR, THE LOSS MUST BE REPORTED TO THE APPROPRIATE LICENSING AGENCY." (EXPIRY DATE: 09/2021).

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING A PROCEDURE, ONE GRAIN OF THE DEVICE WAS ALLEGEDLY FOUND TO BE MISSING FROM THE PARCEL. THERE WAS NO REPORTED PATIENT INJURY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
754754 0.50MCI 1251 BRACHYSOURCE BRACHYTHERAPY EQUIPMENT & ACCESSORIES KXK BARD BRACHYTHERAPY, INC. -1424526 BBFQ0078

Patients

Seq Age Sex Outcome Treatment
1 Unknown Other